Ryan White HIV/AIDS Part B and AIDS Drug Assistance Programs during COVID-19: safety net public health programs' challenges and innovations.
Ryan White HIV/AIDS Part B and AIDS Drug Assistance Programs during COVID-19: safety net public health programs' challenges and innovations.
复制标题
DOI：
10.3389/fpubh.2023.1172009
复制
发表时间：
2023
影响因子：
5.2
通讯作者：
Keim-Malpass, Jessica
中科院分区：
文献类型：
--
作者：
McManus, Kathleen A.;Strumpf, Andrew M.;Killelea, Amy;Horn, Tim;Steen, Amber;An, Zixiao;Schurman, Elizabeth;Hamp, Auntre;Keim-Malpass, Jessica
We characterized the challenges and innovations of states’ Ryan White HIV/AIDS Program (RWHAP) Part B programs, including AIDS Drug Assistance Programs (ADAPs), during the COVID-19 pandemic. In the United States, these are important safety net programs for HIV healthcare, providing essential medical and support services, and medications, to people with HIV with low incomes who are uninsured/underinsured. Data were collected via the 2021-2022 NASTAD National RWHAP Part B and ADAP Monitoring Project Report, a cross-sectional survey of state, district, and territorial programs through a mixed method study design. For quantitative data, we used descriptive statistics. Qualitative responses were coded and analyzed using content analysis. Forty-seven RWHAP Part B and ADAPs responded (92% response rate). The majority of respondents reported that maintaining client eligibility (78%) and working remotely (70%) were the most challenging aspects of the pandemic, particularly in regards to implementing new telehealth and e-certification platforms. In response to COVID-19, programs introduced enrollment “grace periods” (19%), bolstered client outreach (11%), allowed more than a 30 day supply of medications (79%), and supported medication home delivery for clients (80%). Despite the challenges of the COVID-19 pandemic, RWHAP Part B and ADAPs implemented several operational innovations in order to continue providing essential medicines and services. Other public health programs may adopt similar innovations, including digital innovations, for greater public health benefit. Future studies should assess the retention of policy innovations over time, their impact on the individual client level satisfaction or health outcomes, and what factors may improve the acceptability of telehealth and e-certification platforms.
登录
查看更多内容
影响因子：
3.2
作者：
Hsieh, HF;Shannon, SE
通讯作者：
Shannon, SE
影响因子：
11.4
作者：
Hayes, Andrew F.;Krippendorff, Klaus
通讯作者：
Krippendorff, Klaus
影响因子：
2.1
作者：
Sadasivaiah S;Shaffer E;Enanoria W;Su G;Goldman S;Scarafia J;Lee T;Yu A;Goldman LE;Ratanawongsa N
通讯作者：
Ratanawongsa N
DOI：
10.2174/1874613601206010001
发表时间：
2012
期刊：
The open AIDS journal
影响因子：
--
作者：
Z G;M L;H I H;X H;X G;R S
通讯作者：
R S
DOI：
10.1177/0002716213499532
发表时间：
2013-11-01
影响因子：
2.8
作者：
Moffitt, Robert A.
通讯作者：
Moffitt, Robert A.